Literature DB >> 830563

Abnormalities of endogenous glucagon and insulin in unstable diabetes.

C Reynolds, G D Molnar, D L Horwitz, A H Rubenstein, W F Taylor, N S Jiang.   

Abstract

The responses of glucagon, growth hormone, and insulin secretion to the oral administration of glucose and to the intravenous infusion of saline, arginine, and insulin were measured in seven patients who had stable diabetes, eight who had unstable diabetes, and seven healthy volunteers. Hyperglycemia suppressed secretion of glucagon in normal subjects but not in diabetics. The oral glucose and arginine infusion tests demonstrated partial preservation of insulin-secretory ability in stable diabetics and its virxual absence in unstable diabetics. Glucagon responses to arginine infusion were similar in all three groups. In response to hypoglycemia induced by insulin infusion, the concentrations of plasma glucagon increased in normal subjects and, to a lesser extent, in stable diabetics but increased in only two of the unstable diabetics. The impairment in glucagon response during hypoglycemia in diabetics correlated positively with the degree of diabetic instability and insulin deficiency during glucose and arginine testing. The severity of the insulin deficiency also correlated with the degree of diabetic instability. These findings support the hypothesis that inherent abnormalities of insulin and glucagon secretion may account for many of the clinical characteristics of unstable and stable diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 830563     DOI: 10.2337/diab.26.1.36

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

1.  Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes.

Authors:  S Madsbad
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

2.  Brittle diabetes--present concepts.

Authors:  G V Gill; S Walford; K G Alberti
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

3.  The role of glucagon in the regulation of blood glucose: model studies.

Authors:  R Celeste; E Ackerman; L C Gatewood
Journal:  Bull Math Biol       Date:  1978       Impact factor: 1.758

Review 4.  Ameliorative effects of taurine against diabetes: a review.

Authors:  Fengyuan Piao; Rana Muhammad Aadil; Raheel Suleman; Kaixin Li; Mengren Zhang; Pingan Wu; Muhammad Shahbaz; Zulfiqar Ahmed
Journal:  Amino Acids       Date:  2018-02-28       Impact factor: 3.520

5.  Counterregulation in type 2 (non-insulin-dependent) diabetes mellitus. Normal endocrine and glycaemic responses, up to ten years after diagnosis.

Authors:  S R Heller; I A Macdonald; R B Tattersall
Journal:  Diabetologia       Date:  1987-12       Impact factor: 10.122

6.  Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions.

Authors:  G B Bolli; E Tsalikian; M W Haymond; P E Cryer; J E Gerich
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

7.  Factitious diabetes and antibody mediated resistance to beef insulin.

Authors:  A B Kurtz; M G Harrington; J A Matthews; J D Nabarro
Journal:  Diabetologia       Date:  1979-01       Impact factor: 10.122

8.  Variation in 125I-insulin absorption and blood glucose concentration.

Authors:  T Lauritzen; O K Faber; C Binder
Journal:  Diabetologia       Date:  1979-11       Impact factor: 10.122

9.  Plasma C-peptide response to arginine in insulin-dependent diabetic subjects.

Authors:  D Giugliano; A S Luyckx; P J Lefebvre
Journal:  J Endocrinol Invest       Date:  1980 Jan-Mar       Impact factor: 4.256

Review 10.  Methods of assessing diabetic control.

Authors:  G D Molnar; G J Marien; A N Hunter; C H Harley
Journal:  Diabetologia       Date:  1979-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.